Vol. 55 No. 9-10 (2016): Acta Oncologica

Articles

• Delayed anastomotic leakage following bevacizumab administration in colorectal cancer patients

  Mehrdad Jafari, Williams Tessier, Farid El Hajbi, Gauthier Decanter, Xavier Mirabel

  1250-1252

  Published: 2016-10-02

  • PDF

• Dosimetric feasibility of single-energy proton modulated arc therapy for treatment of chordoma at the skull base

  Janid Patricia Blanco Kiely, Benjamin M. White

  1243-1245

  Published: 2016-10-02

  • PDF

• Trends in all-cause five-year mortality after head and neck cancers diagnosed over a period of 33 years. Focus on estimated degree of association with human papillomavirus

  Malene F. Svahn, Christian Munk, Thor S. S. Nielsen, Christian von Buchwald, Kirsten Frederiksen, Susanne K. Kjaer

  1084-1090

  Published: 2016-10-02

  • PDF

• Neurocognitive function of lymphoma patients after treatment with chemotherapy

  Hans Wouters, Joke W. Baars, Sanne B. Schagen

  1121-1125

  Published: 2016-10-02

  • PDF

• Asking the right questions to get the right answers: using cognitive interviews to review the acceptability, comprehension and clinical meaningfulness of patient self-report adverse event items in oncology patients

  Patricia Holch, Lorraine Warrington, Barbara Potrata, Lucy Ziegler, Ceri Hector, Ada Keding, Clare Harley, Kate Absolom, Carolyn Morris, Leon Bamforth, Galina Velikova

  1220-1226

  Published: 2016-10-02

  • PDF

• Early 18F-FDG-PET/CT as a predictive marker for treatment response and survival in patients with metastatic colorectal cancer treated with irinotecan and cetuximab

  Kristin Skougaard, Dorte Nielsen, Benny Vittrup Jensen, Per Pfeiffer, Helle Westergren Hendel

  1175-1182

  Published: 2016-10-02

  • PDF

• Concerns of low-risk thyroid cancer survivors

  Anna M. Sawka, Richard W. Tsang, James D. Brierley, Lorne Rotstein, Phillip Segal, Shereen Ezzat, David P. Goldstein

  1252-1253

  Published: 2016-10-02

  • PDF

• Muscle satellite cell content and mRNA signaling in germ cell cancer patients – effects of chemotherapy and resistance training

  J. F. Christensen, P. Schjerling, J. L. Andersen, G. Daugaard, M. Rørth, A. L. Mackey

  1246-1250

  Published: 2016-10-02

  • PDF

• Effect of calculation method on kidney dosimetry in 177Lu-octreotate treatment

  Jorma Heikkonen, Hanna Mäenpää, Eero Hippeläinen, Vappu Reijonen, Mikko Tenhunen

  1069-1076

  Published: 2016-10-02

  • PDF

• Symptomatic spinal metastasis from intracranial glioblastoma multiforme – Two illustrative cases and a review of the literature

  Mercy Varghese, Hanne Gjertsen Nymoen, Cathrine Saxhaug, Bård Krossnes, Sayied Abdol Mohieb Hosainey, Torstein R. Meling, Petter Brandal

  1236-1238

  Published: 2016-10-02

  • PDF

• Risk of lymph node metastasis and recommendations for elective nodal treatment in squamous cell carcinoma of the nasal cavity and maxillary sinus: a SEER analysis

  Peter H. Ahn, Nandita Mitra, Michelle Alonso-Basanta, James N. Palmer, Nithin D. Adappa, Bert W. O’Malley Jr., Christopher Rassekh, Ara Chalian, Roger B. Cohen, Alexander Lin

  1107-1114

  Published: 2016-10-02

  • PDF

• Sporadic occurrence of non-diagnosed IgG4-related disease in lymphoma patients with a previous Sjögren’s syndrome diagnosis

  Lilian Vasaitis, Christer Sundström, Carin Backlin, Gunnel Nordmark, Eva Baecklund

  1139-1144

  Published: 2016-10-02

  • PDF

• Improvement in survival for patients with synchronous metastatic esophageal cancer in the south of the Netherlands from 1994 to 2013

  N. Bernards, N. Haj Mohammad, G. J. Creemers, T. Rozema, J. A. Roukema, G. A. P. Nieuwenhuijzen, H. W. M. van Laarhoven, M. van der Sangen, V. E. P. P. Lemmens

  1161-1167

  Published: 2016-10-02

  • PDF

• Malignancy associated SIADH: Characterization and clinical implications

  H. Goldvaser, B. Rozen-Zvi, R. Yerushalmi, A. Gafter-Gvili, M. Lahav, D. Shepshelovich

  1190-1195

  Published: 2016-10-02

  • PDF

• Self-rated health and cancer risk – a prospective cohort study among Danish women

  Ida Kristiane Roelsgaard, Anne Marie Olesen, Mette Kildevæld Simonsen, Christoffer Johansen

  1204-1209

  Published: 2016-10-02

  • PDF

• Tailored nurse navigation for women treated for breast cancer: Design and rationale for a pilot randomized controlled trial

  Pernille Envold Bidstrup, Birgitte Goldschmidt Mertz, Niels Kroman, Michael Andersson, Ulla Breitenstein Mathiesen, Jette Vibe-Petersen, Susanne Oksbjerg Dalton, Christoffer Johansen

  1239-1243

  Published: 2016-10-02

  • PDF

• Validation of a 15-gene hypoxia classifier in head and neck cancer for prospective use in clinical trials

  Kasper Toustrup, Brita Singers Sørensen, Mohamed A. Hassan Metwally, Trine Tramm, Lise Saksø Mortensen, Jens Overgaard, Jan Alsner

  1091-1098

  Published: 2016-10-02

  • PDF

• A population-based study of cellular markers in R-CHOP treated diffuse large B-cell lymphoma patients

  Maysaa Abdulla, Sofia Laszlo, Johanna Triumf, Gustaf Hedström, Mattias Berglund, Gunilla Enblad, Rose-Marie Amini

  1126-1131

  Published: 2016-10-02

  • PDF

• Parents of children diagnosed with cancer: work situation and sick leave, a five-year post end-of-treatment or a child’s death follow-up study

  Anna Wikman, Emma Hovén, Martin Cernvall, Gustaf Ljungman, Lisa Ljungman, Louise von Essen

  1152-1157

  Published: 2016-10-02

  • PDF

• Trends in incidence, treatment and survival of small bowel adenocarcinomas between 1999 and 2013: a population-based study in The Netherlands

  Laura M. Legué, Nienke Bernards, Sophie L. Gerritse, Thijs R. van Oudheusden, Ignace H. J. T. de Hingh, Geert-Jan M. Creemers, Albert J. ten Tije, Valery E. P. P. Lemmens

  1183-1189

  Published: 2016-10-02

  • PDF

• Risk of hyperglycemia attributable to everolimus in cancer patients: A meta-analysis

  Kevin Y. Xu, Raji Shameem, Shenhong Wu

  1196-1203

  Published: 2016-10-02

  • PDF

• Asking the right questions to get the right answers: using cognitive interviews to review the acceptability, comprehension and clinical meaningfulness of patient self-report adverse event items in oncology patients

  Patricia Holch, Lorraine Warrington, Barbara Potrata, Lucy Ziegler, Ceri Hector, Ada Keding, Clare Harley, Kate Absolom, Carolyn Morris, Leon Bamforth, Galina Velikova

  1220-1226

  Published: 2016-10-02

  • PDF

• First line treatment with newer tyrosine kinase inhibitors in chronic myeloid leukemia associated with deep and durable molecular response – systematic review and meta-analysis

  Ronit Gurion, Pia Raanani, Liat Vidal, Avi Leader, Anat Gafter-Gvili

  1077-1083

  Published: 2016-10-02

  • PDF

• Health-related quality of life and patient-reported outcomes of ofatumumab plus chlorambucil versus chlorambucil monotherapy in the COMPLEMENT 1 trial of patients with previously untreated CLL

  Peter Hillmen, Ann Janssens, K. Govind Babu, Janusz Kloczko, Sebastian Grosicki, Stephanie Manson, Astrid McKeown, Ira Gupta, Chai-Ni Chang, Fritz Offner

  1115-1120

  Published: 2016-10-02

  • PDF

• Pediatric bone tumors in Germany from 1987 to 2011: incidence rates, time trends and survival

  Peter Kaatsch, Jill Strothotte, Cornelia Becker, Stefan Bielack, Uta Dirksen, Maria Blettner

  1145-1151

  Published: 2016-10-02

  • PDF

• Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers

  Sihem Sebbagh, Julia Roux, Chantal Dreyer, Cindy Neuzillet, Armand de Gramont, Cecilia Orbegoso, Olivia Hentic, Pascal Hammel, Aimery de Gramont, Eric Raymond, Thierry André, Benoist Chibaudel, Sandrine Faivre

  1168-1174

  Published: 2016-10-02

  • PDF

• Book review of “A history of hematology: from Herodotus to HIV”, Shaun R. McCann, Oxford Medical Histories

  Magnus Björkholm

  1254

  Published: 2016-10-02

  • PDF

• Effectiveness of a tailored return to work program for cancer survivors with job loss: results of a randomized controlled trial

  M. P. van Egmond, S. F. A. Duijts, M. A. Jonker, A. J. van der Beek, J. R. Anema

  1210-1219

  Published: 2016-10-02

  • PDF

• Oxaliplatin added to fluoropyrimidine for adjuvant treatment of colorectal cancer is associated with long-term impairment of peripheral nerve sensory function and quality of life

  Måns Stefansson, Peter Nygren

  1227-1235

  Published: 2016-10-02

  • PDF

• Influence of FDG-PET on primary nodal target volume definition for head and neck carcinomas

  Sylvia L. van Egmond, Vera Piscaer, Luuk M. Janssen, Inge Stegeman, Monique G. Hobbelink, Wilko Grolman, Chris H. Terhaard

  1099-1106

  Published: 2016-10-02

  • PDF

• Proton pencil beam scanning for mediastinal lymphoma: treatment planning and robustness assessment

  Chuan Zeng, John P. Plastaras, Paul James, Zelig A. Tochner, Christine E. Hill-Kayser, Stephen M. Hahn, Stefan Both

  1132-1138

  Published: 2016-10-02

  • PDF

• More deaths from pancreatic cancer than breast cancer in the EU by 2017

  J. Ferlay, C. Partensky, F. Bray

  1158-1160

  Published: 2016-10-02

  • PDF

• Superior efficacy and tolerance of reduced doses of vemurafenib plus anakinra in Erdheim-Chester disease: Towards the paradigm of combined targeting and immune therapies

  Fréderic Franconieri, Nicolas Martin-Silva, Hubert de Boysson, Françoise Galateau-Salle, Jean-François Emile, Boris Bienvenu, Achille Aouba

  930-932

  Published: 2016-10-02

  • PDF